Furthermore, pirfenidone, an anti-fibrotic and anti-inflammatory drug used to treat idiopathic pulmonary fibrosis, can prevent scopolamine-induced cognitive impairment41, improve neurological outcome in a rat model of traumatic brain injury42, and inhibit angiotensin II-induced cardiac hypertrophy and fibrosis43. Here, AGT is linked to pulmonary fibrosis.